Some Turner syndromes have been recognized to be associated with neurogenic tumors (Goldberg et al. 1968; Wertelecki and Shapiro 1970) . However, it is rare to associate between Turner syndrome and leukemia (Lewis et al. 1963 ; Dumars et al. 1967; Newman and Gross 1967; Pawliger et al. 1970; Wertelecki and Shapiro 1970; Chaganti et al. 1982) .
This paper describes the first reported case of Turner syndrome in association with acute monocytic leukemia (AMoL). Chromosome analysis of the marrow and peripheral blood showed 45,X mosaicism arid isochromosome 46,X,i(Xq). No further abnormalities were seen in the autosomal chromosome during the course of her treatment for leukemia.
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CASE REPORT
The patient was a married woman with a history of infertility, who was 37 years old at the time of admission. A diagnosis of primary amenorrhea due to ovarian dysplasia had been previously made, and short stature had been noted at the age of 19 years. In 1986, she noticed the onset of easy bruising. In 1987, she developed weight loss with nausea and anorexia, and a temperature of more than 37°C was persistent. On June 28, 1987, she was admitted to our hospital.
Physical findings. Her stature was short (134.5 cm) and her weight was 40.5 kg. She was anemic and hearing loss in the left ear was noted. The blood pressure was 80/40 mmHg. No lymph nodes were palpable, and hepato-splenomegaly was absent. Her temperature was 37.6°C. She lacked pubic and axillary hair, had multiple pigmented nevi, and a low posterior hair line, in addition to short stature. There was also a shield-like chest in association with the wide set nipples and lack of breast development. There was no cubitus valgus or webbed neck, and the remainder of the examination was normal.
Investigation results. The hemogram showed a significant anemia and thrombocytopenia. Leukemic cells were at a level of 25%, and included monocytoid cells with Auer bodies. No impairment of kidney or liver function was found. High serum levels of lysozyme (25.5 pg/ml, normal range : 5-101ug/ml), folic acid (11.6 ng/ml, normal range : 2.3-6.5 ng/ml) and vitamin B12 (1255 pg/ml, normal range : 230-800 pg/ml) were detected. At admission, the bone marrow showed a nucleated cell count of 2.05>< 105/mm3 (Table 1) . Forty-three percent were atypical cells, and the megaloblasts proliferating in the marrow were almost all positive for a-naphthol butyrate esterase staining, which was suppressed after the addition of NaF. A diagnosis of acute monocytic leukemia (AMoL) was made (FAB classification : M5b) (Bennett et al. 1976; Rowley and Golomb 1984) .
Cytogenetic analysis was performed on both the peripheral blood and marrow at her admission. All of G-banded 29 mitoses obtained by the culture of peripheral blood cells without phytohemagglutin (PHA) showed 45,X. The 35 cells analyzed after culture with PHA showed mosaicism of 45,X (29 cells) and 46,X,i(Xq) (6 cells). All the 20 G-banded marrow cells showed only 45,X karyotype ( Fig. 1) .
Endocrine studies. One hour after the intravenous injection of 100,ug of luteinizing hormone-releasing hormone (LH-RH), the plasma LH level increased from 36 mIU/ml (base line, normal range : 0-20 mIU/ml) to 89, 105, 94 and 95 mIl/ml (at 30, 60, 90 and 120 min, TABLE 1. Picture of the peripheral blood and bone marrow Injection of 250,ag of thyroid releasing hormone (TRH) increased the plasma prolactin level from 20 ng/ml (base line, normal range : 0-20 ng/ml) to a one-hour peak level of 280 ng/ml, while there was a normal response of plasma thyroid stimulating hormone (TSH) (1.811U/ ml at base line, normal range : 0-101aU/ml, and 16.3,aU/ml at one hr). The hyperprolactinemia was possibly drug-induced due to metoclopramide which had been given for anorexia. Urinary estrogen excretion (E1, EZ and E3) was decreased. No abnormality was found in thyroid and adrenal function or with respect to the other pituitary hormones ( Table 2 ). The patient's final diagnosis was thus Turner syndrome with a karyotype of 45, X/46,X,i(Xq) in association with AMoL. On June 28, 1988, chemotherapy was started with a regimen of acyl ara-C, daunorubicin, 6-mercaptopurine, and prednisolone for 10 days. This seems unlikely to be the case in Turner syndrome for the following reasons : First, it is extremely infrequent that Turner syndrome associated leukemia, existing only 8 reported cases including the patient described here. Second, among these 8 cases, there was only one with the Phl-positive chromosome, and there were none of the other chromosomal abnormalities which are usually highly prevalent in leukemic disorders. It may be that a low frequency of leukemia is a characteristic of the syndrome, possibly related to low blood estrogen level with high gonadotropin level. Another possibility is that constitutional chromosomal mosaicism inhibits the development of leukemia in Turner syndrome.
